Efficacy and safety of nintedanib in elderly patients with progressive fibrosing interstitial lung diseases (ILDs)*

被引：0
|
作者：
Bonella, Autoren F. [1 ]
Moua, T. [2 ]
Okamoto, M. [3 ]
Tomassetti, S. [4 ]
Valenzuela, C. [5 ]
Wuyts, W. [6 ]
Miede, C. [7 ]
Lievens, D. [8 ]
Bendstrup, E. [9 ]
机构：
[1] Univ Duisburg Essen, Zentrum Interstitielle & Seltene Lungenkrankheite, Klin Pneumol,Univ Med Essen, Ruhrlandklin,Univ Klinikum,Westdeutsch Lungenzent, Duisburg, Germany
[2] Mayo Clin Rochester, Div Pulm & Crit Care Med, Rochester, MN USA
[3] Kurume Univ, Sch Med, Div Respirol Neurol & Rheumatol, Dept Internal Med, Kurume, Fukuoka, Japan
[4] Careggi Univ Hosp, Dept Expt & Clin Med, Florence, Italy
[5] Univ Autonoma Madrid, Hosp Univ Princesa, Madrid, Spain
[6] Univ Hosp Leuven, Dept Pulm Med, Unit Interstitial Lung Dis, Leuven, Belgium
[7] Mainanalyt GmbH, Sulzbach, Germany
[8] Boehringer Ingelheim Int GmbH, Ingelheim, Germany
[9] Aarhus Univ Hosp, Dept Resp Dis & Allergy, Ctr Rare Lung Dis, Aarhus, Denmark
来源：
PNEUMOLOGIE | 2023年 / 77卷
关键词：
D O I：
10.1055/s-0043-1761002
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
Po 256
引用
收藏
页码：S57 / S57
页数：1
相关论文
共 50 条
  • [21] CHARACTERISTICS OF PATIENTS WITH PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASES (ILDS) IN THE ILD-PRO REGISTRY
    Lobo, Leonard
    Liu, Yi
    Li, Peide
    Ramaswamy, Murali
    Swaminathan, Aparna
    Veeraraghavan, Srihari
    Fan, Yanni
    Neely, Megan L.
    Palmer, Scott M.
    Olson, Amy L.
    CHEST, 2023, 164 (04) : 3056A - 3057A
  • [22] The INBUILD Trial of Nintedanib in Patients with Progressive Fibrosing Interstitial Lung Diseases: Subgroup with Autoimmune Diseases
    Matteson, Eric
    Kelly, Clive
    Distler, Joerg
    Mann-Vold, Anna Maria Hoff
    Seibold, James
    Mittoo, Shikha
    Distler, Oliver
    Goeldner, Rainer-Georg
    Schlenker-Herceg, Rozsa
    Stowasser, Susanne
    Quaresma, Manuel
    Flaherty, Kevin
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [23] Nintedanib in patients with chronic fibrosing Interstitial lung diseases with progressive phenotype: the INBUILD trial
    Koschel, D.
    Flaherty, K. R.
    Wells, A. U.
    Cottin, V
    Devaraj, A.
    Inoue, Y.
    Richeldi, L.
    Walsh, S.
    Stowasser, S.
    Coeck, C.
    Goeldner, R. G.
    Clerisme-Beaty, E.
    Schlenker-Herceg, R.
    Brown, K. K.
    PNEUMOLOGIE, 2020, 74 : S106 - S107
  • [24] Nintedanib in patients with progressive fibrosing ILDs in subgroups by comorbidity burden
    Bendstrup, E.
    Moua, T.
    Okamoto, M.
    Tomassetti, S.
    Valenzuela, C.
    Wuyts, A.
    Miede, C.
    Lievens, D.
    Bonella, F.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [25] Progressive fibrosing interstitial lung diseases: A new concept and indication of nintedanib
    Makino, Shigeki
    MODERN RHEUMATOLOGY, 2021, 31 (01) : 13 - 19
  • [26] From Bench to Bedside: Nintedanib for Progressive Fibrosing Interstitial Lung Diseases
    Garlick, Kristopher
    Wollin, Lutz
    Distler, Joerg
    Stowasser, Susanne
    Schlenker-Herceg, Rozsa
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (07) : 822 - 822
  • [27] FROM BENCH TO BEDSIDE: NINTEDANIB FOR PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASES
    Wollin, L.
    Distler, J.
    Redente, E.
    Riches, D.
    Stowasser, S.
    Schlenker-Herceg, R.
    RESPIROLOGY, 2019, 24 : 171 - 171
  • [28] Nintedanib in patients with chronic fibrosing interstitial lung diseases with progressive phenotype: the INBUILD trial
    Flaherty, Kevin R.
    Wells, Athol U.
    Cottin, Vincent
    Devaraj, Anand
    Inoue, Yoshikazu
    Richeldi, Luca
    Walsh, Simon
    Stowasser, Susanne
    Coeck, Carl
    Goeldner, Rainer-Georg
    Clerisme-Beaty, Emmanuelle
    Schlenker-Herceg, Rozsa
    Brown, Kevin K.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [29] Effects of Nintedanib in Patients with Progressive Fibrosing Autoimmune Disease-related Interstitial Lung Diseases (ILDs) in the INBUILD Trial: Subgroups by HRCT Pattern
    Dellaripa, Paul
    Aringer, Martin
    Mann-Vold, Anna Maria Hoff
    Kelly, Clive
    Mittoo, Shikha
    James, Alexandra
    Rohr, Klaus
    Stowasser, Susanne
    Inoue, Yoshikazu
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [30] THE INBUILD TRIAL OF NINTEDANIB IN PATIENTS WITH PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASES: SUBGROUP OF ASIAN PATIENTS
    Inoue, Yoshikazu
    Wells, Athol U.
    Song, Jin Woo
    Xu, Zuojun
    Kitamura, Hideya
    Suda, Takafumi
    Okamoto, Masaki
    Schlenker-Herceg, Rozsa
    Kolb, Martin
    Brown, Kevin K.
    Quaresma, Manuel
    Kolb, Martin
    Brown, Kevin K.
    RESPIROLOGY, 2019, 24 : 87 - 88
12345